Amyris Inc (fka AMRSQ)

[awaitingamove]

It would probably be a wise thing to slowly read the press release for Friday..and read it slowly so you comprehend what is being said..I am sure the analyst will but here is the last paragraph from one of the releases:

Amyris now expects 2017 revenue for the first targeted product of around $40 million and anticipated revenues from the expanded partnership are expected to average over $70 million annually beyond 2017. This expansion is expected to lead to the second molecule to be supplied by Amyris in 2019 into a market that is approximately the same size as the first agreement. These agreements demonstrate the leadership position of Amyris as the only company in industrial biotechnology to produce multiple molecules at a single industrial fermentation facility and with one of the strongest contracted product pipelines in the sector.

Get that last sentence
with one of the strongest contracted product pipelines in the sector.